⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCUL News
Ocular Therapeutix, Inc.
Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD
globenewswire.com
OCUL
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OCUL
Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR
globenewswire.com
OCUL
Ocular Therapeutix™ to Participate in November and December Investor Conferences
globenewswire.com
OCUL
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
globenewswire.com
OCUL